Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,994 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Suspended

Pembrolizumab in Neoplasms or Lymphomas

NCT03316573

Conditions
Dendritic Cell Sarcoma, Follicular, Dendritic Cell Sarcoma, Interdigitating, Follicular Dendritic Cell Sarcoma, +12 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Omaha, Nebraska, United States
View Trial Details
Suspended

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 74 locations
View Trial Details

Related conditions